Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT06576973 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Neoadjuvant Treatment

Interventions

DRUG: Adbelimumab, Albumin paclitaxel, Carboplatin, Apatinib
PROCEDURE: Esophagectomy
OTHER: Collecting samples from participant

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University